Search results
Results from the WOW.Com Content Network
A dried cannabis flower. The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol, and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
In 2014, the startup Meadow began offering on-demand delivery of medical marijuana in the San Francisco Bay Area, through their mobile app. [140] Almost 70% of medical cannabis is exported from the United Kingdom, according to a 2017 United Nations report, with much of the remaining amount coming from Canada and the Netherlands. [141]
Right now, medical marijuana is commonly used to treat nausea, chronic pain, glaucoma and a range of other issues. But that might not be all that the drug can do. Several studies have uncovered ...
Over time, the marijuana gateway hypothesis has been studied more and more. In one published study, the use of marijuana was shown not a reliable gateway cause of illicit drug use. [67] However, social factors and environment influence drug use and abuse, making the gateway effects of cannabis different for those in differing social circumstances.
Cannabis has a longstanding reputation for helping people relax, but recent research has found it can have a negative impact on mental health. For that reason, it's understandable to have questions.
According to Business Insider, only 6% of studies on marijuana focused on the drug's benefits. But there are so many.
On December 17, 2009, Rev. Bryan A. Krumm, CNP, filed a rescheduling petition for Cannabis with the DEA arguing that "because marijuana does not have the abuse potential for placement in Schedule I of the CSA, and because marijuana now has accepted medical use in 13 states, and because the DEA's own Administrative Law Judge has already ...
Research on the medical benefits of cannabis has been hindered by various federal regulations, including its Schedule I classification. [3] To conduct research on cannabis, approval must be obtained from the Food and Drug Administration, [4] and a license must be obtained from the Drug Enforcement Administration specific to Schedule I drugs. [5]